Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> CANTOR FITZGERALD Latest News

MAR 21, 2013 - Benzinga

A Must Read - Share

UPDATE: Cantor Fitzgerald Initiates Cleveland BioLabs at Buy on Improving Valuation

In a report published by Cantor Fitzgerald, analyst Mara Goldstein initiated coverage on Cleveland BioLabs (NASDAQ: CBLI) with a Buy rating and $4 price target. Cantor Fitzgerald reported that, “Cleveland BioLabs is a development stage company with a multi-prong approach to product development.

Tags: UPDATE: Cantor Fitzgerald Initiates Cleveland BioLabs at Buy on Improving Valuation,  Cantor Fitzgerald Latest News